Based on our corporate philosophy: “Contribute toward the improvement of people’s health and progress in medicine through the development of innovative products”, we are engaged in business centered on new drugs with the aim of be a highly competitive specialty pharma company, specializing in three core areas: Internal medicine (Gastroenterology and Thyroid), Obstetrics and Gynecology, and Urology respectively.
The Company's history dates back to 1920, when founder Yasohachi Yamaguchi established Teikoku Hormone Research Institute and began the research, development, manufacture, and sale of hormone preparations based on the unique idea of creating useful medicines from animal organs. With the spirit of always providing pharmaceuticals that meet medical needs, we have overcome various challenges and developed our business together with our stakeholders. This desire of our founder is reflected in our corporate philosophy. In order to realize our corporate philosophy, we will continue to create innovations to solve unmet medical needs in the Company’s three core areas.
Today, the environment surrounding the pharmaceutical industry is undergoing unprecedented change. In response to changes in this environment, "ASKA Pharmaceutical Holdings Co., Ltd." was established in April 2021 and the Medium-Term Management Plan 2025 was initiated. As a core subsidiary of ASKA Pharmaceutical Holdings Co., Ltd., we will solidify our position as a competitive specialty pharma company and contribute to people's health in the entire healthcare market, including disease awareness, prevention, testing, diagnosis, and prognosis, to meet the changing needs of society, while building on our contribution through pharmaceutical products.
We look forward to your continued support.
Sohta Yamaguchi
President, Member of the Board of Directors, Representative Director